thesis question and thesis answer
Thesis question: Who are the patients with COVID-19 that require hospitalization?
Thesis answer: the patients with COVID-19 that require hospitalization because they are at higher risk of getting more damage are 1) are infants who are below the age of twelve months 2) patients with hypercoagulability, which is a medical condition associated with the formation of blood clots in the bloodstream. 3) severely affected patients and would need hospitalization for medical management. 4) older patients.
Entry 1. Evaluation and Management Considerations for Neonates At Risk for COVID-19, Information for Pediatric Healthcare Providers, and the Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children external icon.
Infants below the age of one year are at higher risk than older children because their immune system is not fully developed, and they may need professional management.
Entry 2. National Institutes of Health: Coronavirus Disease 2019 (COVID-19) Treatment Guidelines – Antithrombotic Therapy in Patients with COVID-19external icon
Patients with underlying medical conditions are more likely to require hospitalization because they need the condition managed simultaneously as the virus is also managed.
Entry 3. National Institutes of Health: Coronavirus Disease 2019 (COVID-19) Treatment Guidelinesexternal icon
Patients who are sorely affected need immediate care because they are at higher risk of succumbing to the virus. After all, the disease has overpowered its body defense system.
Entry 4. People Who Are at Increased Risk for Severe Illness
Patients whose age is much advanced are at higher risk of being hospitalized because their immune system needs a boost to manage the disease compared to younger patients whose immune system is at its peak.
References
Jordan, Rachel E., Peymane Adab, and K. K. Cheng. “Covid-19: risk factors for severe disease and death.” (2020).
Ryan, Donna H., Eric Ravussin, and Steven Heymsfield. “COVID 19 and the patient with obesity–the editors speak out.” Obesity (Silver Spring, Md.) (2020).
Mitjà, Oriol, and Bonaventura Clotet. “Use of antiviral drugs to reduce COVID-19 transmission.” The Lancet Global Health 8.5 (2020): e639-e640.
Li, Wei, et al. “Chest computed tomography in children with COVID-19 respiratory infection.” Pediatric radiology (2020): 1-4.
Riphagen, Shelley, et al. “Hyperinflammatory shock in children during COVID-19 pandemic.” The Lancet 395.10237 (2020): 1607-1608.
Parri, Niccolò, Matteo Lenge, and Danilo Buonsenso. “Children with Covid-19 in pediatric emergency departments in Italy.” New England Journal of Medicine (2020).
Clark, Andrew, et al. “Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study.” The Lancet Global Health (2020).
Covid, C. D. C., et al. “Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019—United States, February 12–March 28, 2020.” Morbidity and Mortality Weekly Report 69.13 (2020): 382.
Lee, Ping-Ing, et al. “Are children less susceptible to COVID-19?.” Journal of Microbiology, Immunology, and Infection (2020).
Brooke, Joanne, and Debra Jackson. “Older people and COVID‐19: Isolation, risk and ageism.” Journal of clinical nursing (2020).
Lloyd-Sherlock, Peter, et al. “Bearing the brunt of covid-19: older people in low and middle income countries.” (2020).
Osama, Tasnime, Bharat Pankhania, and Azeem Majeed. “Protecting older people from COVID-19: should the United Kingdom start at age 60?.” Journal of the Royal Society of Medicine 113.5 (2020): 169-170.
Jiménez-Pavón, David, Ana Carbonell-Baeza, and Carl J. Lavie. “Physical exercise as therapy to fight against the mental and physical consequences of COVID-19 quarantine: Special focus in older people.” Progress in cardiovascular diseases (2020).